Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

3.3%

4 terminated/withdrawn out of 120 trials

Success Rate

89.5%

+2.9% vs industry average

Late-Stage Pipeline

8%

10 trials in Phase 3/4

Results Transparency

12%

4 of 34 completed trials have results

Key Signals

6 recruiting4 with results

Enrollment Performance

Analytics

N/A
56(70.0%)
Phase 2
12(15.0%)
Phase 4
7(8.8%)
Phase 3
3(3.8%)
Phase 1
2(2.5%)
80Total
N/A(56)
Phase 2(12)
Phase 4(7)
Phase 3(3)
+1 more

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (120)

Showing 20 of 120 trials
NCT05982223Not ApplicableRecruiting

Integrative Medicine in Lymphoma Survivors

Role: lead

NCT05982249Not ApplicableCompleted

Hypnosis and Virtual Reality in Bone Marrow Examination

Role: lead

NCT07851558Not ApplicableCompleted

Early Mobilization and No Urinary Catheter After Cesarean for Improved Post Operative Recovery: A Randomized Trial

Role: lead

NCT05982262Not ApplicableCompleted

Naturopathic-pharmacological Consultation in Hematology

Role: lead

NCT06515249Not ApplicableRecruiting

Integrative Therapies in Multiple Myeloma

Role: lead

NCT06190964Not ApplicableRecruiting

Integrative Medicine for Hospital Workers Exposed to War

Role: lead

NCT06510530Phase 3Not Yet Recruiting

Astragalus for Symptomatic Alleviation in High-grade Lymphoma

Role: lead

NCT07690761Phase 2Enrolling By Invitation

Rituximab+ Zanubrutinib for Patients With Hairy Cell Leukemia and Hairy Cell Variant

Role: lead

NCT05489380Not ApplicableCompleted

Optical Diagnosis Versus Laser Measurement of Polyps' Size During Colonoscopy and Implications for Surveillance

Role: collaborator

NCT07356258Not Yet Recruiting

Oral Iron in Pregnant Women: How Often to Take It and Its Side Effects and Tolerability

Role: lead

NCT07323901Not ApplicableEnrolling By Invitation

GRAPE-GDM Prospective Comperative Trial - Grape Juice as a Replacement Drink for Gestational Diabetes Screening

Role: lead

NCT02399124Not ApplicableActive Not Recruiting

Post Marketing Surveillance for PROSENSE™ a Cryotherapy Treatment of Renal Cell Carcinoma

Role: collaborator

NCT07288021Phase 4Recruiting

Topical Anesthesia During Catheter Insertion for Cervical Ripening (TOLERANCE)

Role: lead

NCT06966557Recruiting

Nerve Block Treatment for Chronic Jaw Pain

Role: lead

NCT01733771Not ApplicableCompleted

The Effect of Complementary Medicine (CAM) Treatments on Common Symptoms in Hospitalized Patients

Role: lead

NCT06865716Not ApplicableActive Not Recruiting

Effects of Early Vagus Nerve Stimulation on Infarct Damage and Functioning After Acute STEMI

Role: lead

NCT04939363Phase 2Completed

A Study to Evaluate Efficacy & Safety of Obinutuzumab, Ibrutinib, and Venetoclax in Richter's Syndrome;

Role: lead

NCT06598813Completed

Pediatric Headche Assessment Using HIT 6

Role: lead

NCT06581185Enrolling By Invitation

Pseudotumor Cerebri Headache Ten Years Outcome

Role: lead

NCT03290976Not ApplicableCompleted

Integrative Medicine for Chemotherapy-Induced Peripheral Neuropathy

Role: collaborator